Key Highlights
- 21.3 is the 14-day RSI for Caesars (NASDAQ:CZR) per published market data (October 16, 2026 intraday), with the price at USD 29.07, down 1.67% over a week. An October 13 snapshot showed RSI at 45.85; the conflict was not reconciled.
- USD 31.00 in cash per share is the price Fertitta Entertainment agreed to pay, announced May 28, 2026, valuing the deal at USD 17.6 billion including USD 11.9 billion of assumed debt. The gross spread to the intraday price is 6.6% (own arithmetic).
- September 14, 2026 is when the Federal Trade Commission issued a second request, extending review. Shareholders approved the merger on September 22, 2026, with 65.4% of outstanding shares voting in favor, so Caesars (NASDAQ:CZR) now awaits antitrust and gaming approvals.
- October 27, 2026 is the third quarter report date per the company announcement of October 2, 2026. Trailing revenue is USD 11.65 billion with a net loss of USD 465 million, per published market data.
The Deal Sets the Price
The stake is unusual: the stock is oversold on a momentum gauge while tethered to a contractual cash price. Caesars (NASDAQ:CZR) is priced against USD 31.00 in cash, so the USD 1.93 spread is own arithmetic on two numbers and equals 6.6% of the price. Closing on the first outside date of May 27, 2027 would imply a 10.9% annualised gross return (own arithmetic, 223 days, not a forecast). A ticking fee of USD 0.00715 per share per day starts after June 26, 2027. No company-specific catalyst for the RSI reading was identified in the filings and releases reviewed through October 16, 2026.
Regulatory and Termination Mechanics
The outside date extends automatically to August 27, 2027 and November 27, 2027 if only antitrust and gaming approvals remain. Fertitta Gaming Holdco owes a USD 450 million reverse termination fee if antitrust or gaming law blocks the merger, while Caesars owes USD 200 million in specified cases. The FTC second request and the resignation of two Icahn-backed directors, reported September 18, 2026, lengthen the timeline. Merger arbitrage works by buying below the offer and collecting the spread at closing, so a delay widens the annualised cost and pressures the price without changing the deal terms.
Valuation, Positioning and Risks
The 52-week range is USD 17.86 to USD 30.88, putting the price 5.9% below the high (own arithmetic). The 50-day average of USD 29.69 and the 200-day of USD 27.31 were published October 13, 2026, putting the price 2.1% below the 50-day. Short interest was 10.12% of shares outstanding, consistent with arbitrage positioning, though the composition is not confirmed. TD Cowen downgraded the stock to Hold on the deal, and consensus is Hold with a USD 31.27 target. If the deal fails, the stock would trade on operating results, which show losses.
Where Things Stand
The 21.3 RSI reflects a thin, deal-capped trading range, not confirmed weakness in the business: Caesars (NASDAQ:CZR) is oversold on a 14-session momentum measure, but the price remains tied to USD 31.00 in cash. Evidence is mixed: shareholder approval removes one hurdle, while the FTC second request and gaming approvals keep the closing date open, and the RSI conflicts with another snapshot. Mean reversion toward USD 31.00 is a deal-timing outcome, not a momentum one, and RSI is not a forecast. The next catalyst is the October 27, 2026 report.






Please wait processing your request...